Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation

American Journal of Pathology

Volumn 169, Issue 2, 2006, Pages 665-672

  Tormo, Damia ^a   Ferrer, Aleix ^a   Gaffal, Evelyn ^a   Wenzel, Jörg ^a   Basner Tschakarjan, Etiena ^a   Steitz, Julia ^a   Heukamp, Lukas C ^a   Gütgemann, Ines ^a   Buettner, Reinhard ^a   Malumbres, Marcos ^b   Barbacid, Mariano ^b   Merlino, Glenn ^c   Tüting, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; CYCLIN DEPENDENT KINASE 4; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN TYROSINE KINASE; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; LATENT PERIOD; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 33746635503     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060017     Document Type: Article

References (37)

1. Tsao H, Atkins MB, Sober AJ: Management of cutaneous melanoma. N Engl J Med 2004, 351:998-1012
2. Chudnovsky Y, Khavari PA, Adams AE: Melanoma genetics and the development of rational therapeutics. J Clin Invest 2005, 115:813-824
3. Chin L: The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003, 3:559-570
4. Chin L, Merlino G, DePinho RA: Malignant melanoma: modern black plague and genetic black box. Genes Dev 1998, 12:3467-3481
5. Walker GJ, Hayward NK: Pathways to melanoma development: lessons from the mouse. J Invest Dermatol 2002, 119:783-792
6. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353:2135-2147
7. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A: Loss of p16lnk4a confers susceptibility to metastatic melanoma in mice. Nature 2001, 413:83-86
8. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA: Loss of p16lnk4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001, 413:86-91
9. Sotillo R, Garcia JF, Ortega S, Martin J, Dubus P, Barbacid M, Malumbres M: Invasive melanoma in Cdk4-targeted mice. Proc Natl Acad Sci USA 2001, 98:13312-13317
10. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De PE, Hankeln T, Meyer zum Buschenfelde KH, Beach D: A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995, 269:1281-1284
11. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC: Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996, 12:97-99
12. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA: Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954
13. Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G, Ruzicka T, Hengge UR: Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol 2005, 141:165-173
14. Natali PG, Nicotra MR, Di Renzo MF, Prat M, Bigotti A, Cavaliere R, Comoglio PM: Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer 1993, 68:746-750
15. Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, Van BP, Elder DE, Herlyn M: Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 2003, 63:756-759
16. Powell MB, Hyman P, Bell OD, Balmain A, Brown K, Alberts D, Bowden GT: Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter. Mol Carcinog 1995, 12:82-90
17. Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G: c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 1998, 58:5157-5167
18. Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G: Neonatal sunburn and melanoma in mice. Nature 2001, 413:271-272
19. Steitz J, Bruck J, Gambotto A, Knop J, Tuting T: Genetic immunization with a melanocytic self-antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity. Gene Ther 2002, 9:208-213
20. Steitz J, Bruck J, Lenz J, Knop J, Tuting T: Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res 2001, 61:8643-8646
21. Steitz J, Bruck J, Steinbrink K, Enk A, Knop J, Tuting T: Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer 2000, 86:89-94
22. Steitz J, Buchs S, Tormo D, Ferrer A, Wenzel J, Huber C, Wolfel T, Barbacid M, Malumbres M, Tuting T: Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against autochthonous melanomas in the skin. Int J Cancer 2006, 118:373-380
23. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999, 22:44-52
24. Berkelhammer J, Oxenhandler RW: Evaluation of premalignant and malignant lesions during the induction of mouse melanomas. Cancer Res 1987, 47:1251-1254
25. Broome PM, Gause PR, Hyman P, Gregus J, Lluria-Prevatt M, Nagle R, Bowden GT: Induction of melanoma in TPras transgenic mice. Carcinogenesis 1999, 20:1747-1753
26. Quintanilla M, Brown K, Ramsden M, Balmain A: Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 1986, 322:78-80
27. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003, 4:915-925
28. Man J, Tsukada Y, Hara E, Kitamura N, Tanaka T: Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells. J Biol Chem 2005, 280:31548-31556
29. Rane SG, Cosenza SC, Mettus RV, Reddy EP: Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol Cell Biol 2002, 22:644-656
30. Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F: Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res 2005, 65:4005-4011
31. Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner JW, DePinho RA: Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev 1997, 11:2822-2834
32. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, Cordon-Cardo C, Yancopoulos GD, DePinho RA: Essential role for oncogenic Ras in tumour maintenance. Nature 1999, 400:468-472
33. Recio JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL, Lindner G, De Fabo EC, DePinho RA, Merlino G: Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res 2002, 62:6724-6730
34. Sharp R, Recio JA, Jhappan C, Otsuka T, Liu S, Yu Y, Liu W, Anver M, Navid F, Helman LJ, DePinho RA, Merlino G: Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat Med 2002, 8:1276-1280
35. Comoglio PM, Trusolino L: Invasive growth: from development to metastasis. J Clin Invest 2002, 109:857-862
36. Gentile A, Comoglio PM: Invasive growth: a genetic program. Int J Dev Biol 2004, 48:451-456
37. Li G, Schaider H, Satyamoorthy K, Hanakawa Y, Hashimoto K, Herlyn M: Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 2001, 20:8125-8135